Lung PET-CT Scan: Uses, Procedure, Test Details and Accuracy

Lung cancer is one of the major types of cancer affecting the respiratory system. Imaging tests are also used when lung cancer is suspected or diagnosed to learn more about the size, area, activity, and potential spread of the cancer in the lungs. Lung PET-CT Imaging is a combination of two imaging techniques, positron emission tomography (PET) and computed tomography (CT) imaging, performed in a single examination.

Functional and anatomical information can be obtained from a PET- CT scan. In PET, a radiotracer is given in the body, and it indicates regions of higher metabolic activity, whereas in CT, detailed images of the body's structures are obtained. The combination of this clinical appropriateness and the data can be used to assess lung cancer and make further clinical decisions when a scan is clinically appropriate.

Molecular Diagnostics and Therapy advanced imaging services assist physicians in the evaluation of patients who have been recommended for a PET-CT as part of their cancer assessment.

What Is a Lung PET-CT Scan?

A lung PET-CT scan is an imaging test that combines PET and CT scans. A radiotracer called FDG (fluorodeoxyglucose) is used for many cancer-related PET-CT scans. FDG is metabolised like glucose, and tissue with higher metabolic activity might take up more. The PET part is used to identify metabolism, and the CT part is used for visualizing the anatomy with great detail. When both sets of information are put together, physicians can better determine and narrow down areas to investigate further.

Why Is PET-CT Used for Lung Cancer?

Depending on the clinical situation, a PET-CT may be considered in individual patients who have a diagnosed or suspected case of lung cancer. A very important function is to assess the level of cancer once it has been diagnosed. It could aid in determining if abnormal activity is detected in parts of the body other than the lymph nodes. 

This information can be part of the planning for staging of the cancer and may be used by the cancer team to determine whether surgery, radiation therapy, systemic therapy, or other treatment is appropriate. Depending on the patient's situation, PET-CT may also be ordered to see how well the treatment is working or to check for the presence of any recurring disease after treatment.

When May a Lung PET-CT Be Recommended?

PET-CT is considered by doctors when there is a lung abnormality that needs to be evaluated or when lung cancer has been identified and the extent of disease needs to be known. It may be taken into account in some indeterminate lung nodules, depending on the size, appearance, clinical history, and other imaging factors. But this does not mean it should be performed on every person who experiences respiratory symptoms or is someone with a lung nodule. The clinical scenario is used to decide this.

How Does a Lung PET-CT Scan Work?

A small amount of radiotracer is often given intravenously before the scan. The patient then lies completely still while the tracer moves around the body and gets absorbed into the tissues. Proper preparation is important for obtaining good-quality FDG PET-CT images, meaning that food is often eliminated for several hours prior to the test; however, water is usually permitted. Blood sugar may also be sampled, as elevated blood glucose could have an impact on PET findings. Depending on the imaging centre and examination, it may be necessary to make different preparations.

One waits a certain amount of time, and then the patient lies on the table he or she is to be scanned on. First the CT scan, then a PET scan. All patients will be required to lie completely still during the scan to ensure a proper picture is captured. The scanning time is typically 20 to 30 minutes, but will depend on the appointment time, as preparation time will also be required, as well as the time the radiotracer takes to circulate.

What Does a Lung PET-CT Show?

Lung PET-CT can provide information on both the structure and the metabolism of tissues. CT scans may be able to detect the size and location of nodules or masses in the lungs, and give details of structures in the proximity. The PET images can reveal regions with higher levels of "uptake" of the tracer. This information can be valuable in the evaluation of lung cancer to detect metabolically active disease and to evaluate for possible metastases or involvement of lymph nodes.

But a high FDG uptake doesn't necessarily imply cancer. A state of inflammation and infection can also exhibit a higher metabolic rate. In the same way, there are instances where cancer uptake of FDG may be somewhat weak. Hence, the results from a PET-CT should be evaluated in conjunction with symptoms, past medical history, CT, and other investigations.

Is PET-CT Accurate for Lung Cancer?

Caution should be taken when using the term accuracy with PET-CT. PET-CT can be useful in assessing cancer spread and metabolic activity, but does not always confirm a diagnosis of cancer. If they discover something suspicious using PET-CT (a procedure which uses a special machine that captures radiation emitted by body tissues), further tests may be performed. Tissue sampling by biopsy is also performed in a lot of suspected cases of lung cancer to confirm the diagnosis. Biopsy might be done with bronchoscopy or by techniques performed with computed tomography (CT) guidance, depending on where the abnormality is located. PET-CT may thus be valuable in the diagnosis or staging process, although results must be evaluated in conjunction with other tests and/or clinical data.

PET-CT for Lung Cancer Staging

The stage of lung cancer is a measurement of the depth of disease or whether it is spread. In non-small-cell lung cancer and in some small-cell lung cancer (SCLC) cases, PET-CT may be useful in staging. Depending on the patient's condition, physicians might make use of PET-CT alongside different imaging tests (including brain MRI) and/or biopsy and lab tests. The specific tests will depend on the type of cancer being considered and what information is available.

Can PET-CT Be Used After Lung Cancer Treatment?

Yes, in selected situations. PET-CT may help doctors assess how a cancer responds to treatment or evaluate suspected recurrence after treatment. Changes in metabolic activity can sometimes provide useful information about treatment response. However, treatment-related inflammation can also affect PET findings, so scan results need to be interpreted in the context of the timing of treatment and other clinical information.

Is a Lung PET-CT Scan Safe?

PET-CT involves exposure to radiation from both the radiotracer and CT component. The amount used for diagnostic imaging is kept as low as reasonably appropriate for the examination, and the potential benefits are considered against the radiation risk. The radiotracer itself is used in a small amount and loses radioactivity over time. It is also eliminated from the body naturally, including through urine. Drinking water after the examination may help with clearance unless the healthcare team gives different instructions. Patients should inform their doctor and imaging team if they are pregnant or breastfeeding.

How to Prepare for a Lung PET-CT Scan

Preparation instructions should always be followed as provided by the imaging centre. For many FDG PET-CT examinations, patients are asked not to eat for several hours before the scan and to drink water as instructed. People with diabetes may receive specific instructions because blood glucose levels can affect the quality and interpretation of an FDG PET scan. Patients should also inform the medical team about their medicines, medical conditions, recent illnesses, and any previous imaging or treatment.

Understanding Your PET-CT Report

A PET-CT report is usually prepared by a radiologist or nuclear medicine physician trained in interpreting these examinations. The report may describe findings in the lungs, lymph nodes, other organs, and bones depending on the area scanned. The report may also include an Impression or Conclusion, where the most important findings and recommendations are summarized. If a finding is uncertain, the report may recommend another imaging test, follow-up, or tissue sampling. Patients should discuss their report with the treating doctor rather than trying to interpret individual terms without clinical context.

Why Choose Molecular Diagnostics and Therapy for PET-CT?

Molecular Diagnostics and Therapy provides advanced diagnostic services, including PET-CT imaging, to support doctors in evaluating various conditions. The centre uses modern imaging technology and provides PET-CT services based on clinical requirements. For patients undergoing evaluation for lung cancer, PET-CT findings can provide useful information about metabolic activity and the possible extent of disease. The final interpretation should always be considered along with the patient's clinical history, previous imaging, biopsy findings, and other relevant investigations.

Conclusion

It can be helpful in selected patients with lung cancer for lymph node evaluation, staging, treatment-response assessment, and evaluation of suspected recurrence. PET/CT is useful, but cannot definitively diagnose lung cancer in all situations. Other diseases and inflammation may also alter PET results, and a biopsy is often needed to confirm a diagnosis of lung cancer by examining tissue. Following your doctor's advice on preparation for a PET-CT scan for lung cancer and discussing the end result with the doctor treating you is a way to ensure that the results are considered in the proper clinical context.